Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Zinonos

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Materials Chemistry. B|April 9, 2020
In vivo toxicological assessment of electrochemically engineered anodic alumina nanotubes: a study of biodistribution, subcutaneous implantation and intravenous injectionYe Wang, Irene Zinonos, Aneta Zysk, et al.
Biomaterials|June 13, 2016
Titanium wire implants with nanotube arrays: A study model for localized cancer treatmentGagandeep Kaur, Tamsyn Willsmore, Karan Gulati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Nutlin-3a is a potential therapeutic for ewing sarcomaKathleen I Pishas, Fares Al-Ejeh, Irene Zinonos, et al.
The International Journal of Biochemistry & Cell Biology|September 20, 2015
Uncovering a new role for peroxidase enzymes as drivers of angiogenesisVasilios Panagopoulos, Irene Zinonos, Damien A Leach, et al.
International Journal of Oncology|March 6, 2017
Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironmentVasilios Panagopoulos, Damien A Leach, Irene Zinonos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 7, 2010
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
Molecular Cancer Therapeutics|October 8, 2009
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
Calcified Tissue International|December 9, 2015
Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human OsteoblastsMark O DeNichilo, Alexandra J Shoubridge, Vasilios Panagopoulos, et al.
Cancer Letters|November 21, 2016
Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancerAneta Zysk, Mark O DeNichilo, Vasilios Panagopoulos, et al.
Anticancer Research|December 16, 2014
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs)Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Materials Chemistry. B|April 9, 2020
In vivo toxicological assessment of electrochemically engineered anodic alumina nanotubes: a study of biodistribution, subcutaneous implantation and intravenous injectionYe Wang, Irene Zinonos, Aneta Zysk, et al.
Biomaterials|June 13, 2016
Titanium wire implants with nanotube arrays: A study model for localized cancer treatmentGagandeep Kaur, Tamsyn Willsmore, Karan Gulati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Nutlin-3a is a potential therapeutic for ewing sarcomaKathleen I Pishas, Fares Al-Ejeh, Irene Zinonos, et al.
The International Journal of Biochemistry & Cell Biology|September 20, 2015
Uncovering a new role for peroxidase enzymes as drivers of angiogenesisVasilios Panagopoulos, Irene Zinonos, Damien A Leach, et al.
International Journal of Oncology|March 6, 2017
Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironmentVasilios Panagopoulos, Damien A Leach, Irene Zinonos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 7, 2010
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
Molecular Cancer Therapeutics|October 8, 2009
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
Calcified Tissue International|December 9, 2015
Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human OsteoblastsMark O DeNichilo, Alexandra J Shoubridge, Vasilios Panagopoulos, et al.
Cancer Letters|November 21, 2016
Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancerAneta Zysk, Mark O DeNichilo, Vasilios Panagopoulos, et al.
Anticancer Research|December 16, 2014
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs)Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, et al.
Pageof 2